| Income Statement |
| Operating Expenses | 27.80M |
|
| Research and Development Expense | 1.14M |
| Selling, General and Administrative Expense | 26.66M |
| Operating Income | -27.80M |
| Interest Expense | 700.00K |
| Net Income | 545.10M |
| Net Income Common Stock | 545.10M |
| Net Income Common Stock (USD) | 545.10M |
| Consolidated Income | 545.10M |
| Earning Before Interest & Taxes (EBIT) | 545.80M |
| Earning Before Interest & Taxes (USD) | 545.80M |
| Weighted Average Shares | 55.41M |
| Balance Sheet |
| Cash and Equivalents | 102.88M |
| Cash and Equivalents (USD) | 102.88M |
| Trade and Non-Trade Receivables | 4.00K |
| Current Assets | 106.03M |
| Property, Plant & Equipment Net | 102.00K |
| Total Assets | 106.14M |
| Current Liabilities | 3.16M |
| Total Liabilities | 199.73M |
| Accumulated Retained Earnings (Deficit) | -607.28M |
| Accumulated Other Comprehensive Income | -10.10M |
| Shareholders Equity | -93.59M |
| Shareholders Equity (USD) | -93.59M |
| Assets Non-Current | 102.00K |
| Liabilities Non-Current | 196.57M |
| Trade and Non-Trade Payables | 1.15M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 10.00K |
| Net Cash Flow from Financing | 106.50M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 99.88M |
| Capital Expenditure | -14.00K |
| Issuance (Purchase) of Equity Shares | 106.70M |
| Issuance (Repayment) of Debt Securities | -198.00K |
| Net Cash Flow from Investing | -14.00K |
| Net Cash Flow from Operations | -6.61M |
| Effect of Exchange Rate Changes on Cash | 850.00K |
| Share Based Compensation | 19.73M |